PMID: 12891548

Rosmorduc O, Hermelin B, Boelle PY, Parc R, Taboury J, Poupon R
ABCB4 gene mutation-associated cholelithiasis in adults.
Gastroenterology. 2003 Aug;125(2):452-9., [PubMed]
Sentences
No. Mutations Sentence Comment
63 ABCB4 p.Arg590Gln
X
ABCB4 p.Arg590Gln 12891548:63:272
status: NEW
view ABCB4 p.Arg590Gln details
ABCB4 p.Gly742Ser
X
ABCB4 p.Gly742Ser 12891548:63:286
status: NEW
view ABCB4 p.Gly742Ser details
However, because these mutations affected nonconserved amino acids between the human ABCB4 gene and its rodent homologs, they were not considered as DCMs.13, 14 They were localized in the third intracellular loop and in the fourth extracellular loop of the protein (e.g., Arg590Gln and Gly742Ser). Login to comment
67 ABCB4 p.Arg652Gly
X
ABCB4 p.Arg652Gly 12891548:67:23
status: NEW
view ABCB4 p.Arg652Gly details
A previously described Arg652Gly SNP was detected at a similar frequency (approximately 5%) in patients with and Table 3. Login to comment
68 ABCB4 p.Thr175Ala
X
ABCB4 p.Thr175Ala 12891548:68:198
status: NEW
view ABCB4 p.Thr175Ala details
ABCB4 p.Glu528Asp
X
ABCB4 p.Glu528Asp 12891548:68:449
status: NEW
view ABCB4 p.Glu528Asp details
ABCB4 p.Ser320Phe
X
ABCB4 p.Ser320Phe 12891548:68:284
status: NEW
view ABCB4 p.Ser320Phe details
ABCB4 p.Ala934Thr
X
ABCB4 p.Ala934Thr 12891548:68:793
status: NEW
view ABCB4 p.Ala934Thr details
ABCB4 p.Phe165Ile
X
ABCB4 p.Phe165Ile 12891548:68:143
status: NEW
view ABCB4 p.Phe165Ile details
ABCB4 p.Met301Thr
X
ABCB4 p.Met301Thr 12891548:68:250
status: NEW
view ABCB4 p.Met301Thr details
ABCB4 p.Arg788Glu
X
ABCB4 p.Arg788Glu 12891548:68:713
status: NEW
view ABCB4 p.Arg788Glu details
ABCB4 p.Leu591Gln
X
ABCB4 p.Leu591Gln 12891548:68:498
status: NEW
view ABCB4 p.Leu591Gln details
ABCB4 Gene Mutations in Patients With LPAC Syndrome Gene position Location and nucleotide change Peptide change Protein domain Status 6 495T3A Phe165Ile First intracellular loop Heterozygous 523T3C Thr175Ala between TM2 and TM3 Heterozygous 9 902T3C Met301Thr TM5 Heterozygous 959C3T Ser320Phe TM5 Homozygous 10 1007-1015insT 355Stop TM6 Heterozygous 1007-1015delT 341Stop TM6 Heterozygous 12 1327insA 447Stop Close to NBD11 Heterozygous 14 1584G3C Glu528Asp Close to NBD11 Heterozygous 15 1772T3A Leu591Gln Third intracellular loop Homozygous 17 1973G3A Try658Stop Third intracellular loop linker domain Heterozygous 18 2270-2273insT 793Stop Fourth intracellular loop between TM8 and TM9 Heterozygous 19 2363G3T Arg788Glu Fourth intracellular loop between TM8 and TM9 Heterozygous 23 2800G3T Ala934Thr Fifth intracellular loop between TM10 and TM11 Homozygous 26 3481C3T Pro1161Ser Close to NBD2 Heterozygous NOTE. The A of ATG of the initiator Met codon was denoted as "nucleotide ϩ 1." Login to comment
90 ABCB4 p.Arg652Gly
X
ABCB4 p.Arg652Gly 12891548:90:340
status: NEW
view ABCB4 p.Arg652Gly details
Characterization of ABCB4 Gene SNPs and Determination of the Main Allele Frequency in Patients With and Without LPAC Syndrome and in Control Subjects SNP1 SNP2 SNP3 SNP4 SNP5 SNP characteristics SNP localization Exon 4 Exon 5 Exon 6 Exon 8 Exon 16 Nucleotide change 175C3T 342T3C 504C3T 711A3T 1954A3G Amino acid Leu59 Thr114 Asn168 Ile237 Arg652Gly Most frequent allele CTG ACT AAC ATA AGG Group of patients and controls Mutation, LPAC phenotype (score Ն2) 21/24 (87.5%) 24/24 (100%) 16/30 (53.3%) 21/24 (87.5%) 23/24 (95.8%) No mutation, LPAC phenotype (score Ն2) 27/28 (96.4%) 27/28 (96.4%) 3/28 (10.7%) 27/28 (96.4%) 27/28 (96.4%) No mutation, no LPAC phenotype (score Ͻ2) 52/56 (92.8%) 56/56 (100%) 29/56 (51.8%) 51/56 (91.1%) 51/56 (91.1%) Control subjects 54/66 (81.8%) 65/66 (98.5%) 36/66 (54.5%) 50/66 (89.3%) 61/66 (92.4%) Bonferroni-adjusted P value (5 comparisons) 0.05 0.99 0.001 0.14 0.99 NOTE. The table indicates the most frequent allele to total number of alleles ratio for each tested SNP in the different groups of patients. Login to comment
96 ABCB4 p.Thr175Ala
X
ABCB4 p.Thr175Ala 12891548:96:31
status: NEW
view ABCB4 p.Thr175Ala details
ABCB4 p.Thr175Ala
X
ABCB4 p.Thr175Ala 12891548:96:148
status: NEW
view ABCB4 p.Thr175Ala details
ABCB4 p.Glu528Asp
X
ABCB4 p.Glu528Asp 12891548:96:45
status: NEW
view ABCB4 p.Glu528Asp details
Two of the missense mutations (Thr175Ala and Glu528Asp) detected in the patients with the LPAC syndrome were analyzed previously in yeast.23,24 The Thr175Ala mutation was localized in the first intracellular loop and resulted in a substitution in a conserved cluster of 4 amino acids at position 169-172, which is required for the adenosine triphosphatase activity of the molecule. Login to comment
98 ABCB4 p.Phe165Ile
X
ABCB4 p.Phe165Ile 12891548:98:4
status: NEW
view ABCB4 p.Phe165Ile details
The Phe165Ile mutation was localized in the same part of this intracellular loop and might thereby give rise to a similar defect. Login to comment
99 ABCB4 p.Glu528Asp
X
ABCB4 p.Glu528Asp 12891548:99:4
status: NEW
view ABCB4 p.Glu528Asp details
The Glu528Asp mutation was localized close to the NBD1. Login to comment
102 ABCB4 p.Thr175Ala
X
ABCB4 p.Thr175Ala 12891548:102:37
status: NEW
view ABCB4 p.Thr175Ala details
The 2 unrelated patients in whom the Thr175Ala mutation was identified originated from Northern Europe, so they may have inherited a founder mutation from a shared ancestor. Login to comment
105 ABCB4 p.Ser320Phe
X
ABCB4 p.Ser320Phe 12891548:105:280
status: NEW
view ABCB4 p.Ser320Phe details
ABCB4 p.Ala934Thr
X
ABCB4 p.Ala934Thr 12891548:105:293
status: NEW
view ABCB4 p.Ala934Thr details
In addition, the LPAC syndrome was observed in patients with similar nonsense or missense mutations: in a mother and her elder son with an identical heterozygous nonsense mutation (1327insA); in patients from nonconsanguineous families with the same homozygous missense mutation (Ser320Phe or Ala934Thr) with asymptomatic heterozygous parents; in patients with a similar nonsense mutation (1006-1016insT and 1006-1016delT); and in unrelated patients with the same missense mutations (Pro1161Ser). Login to comment
106 ABCB4 p.Ser320Phe
X
ABCB4 p.Ser320Phe 12891548:106:17
status: NEW
view ABCB4 p.Ser320Phe details
In addition, the S320F mutation was recently identified in a patient who presented with ICP and cholelithiasis.5 For these reasons, all these mutations could be considered as causing the LPAC syndrome. Login to comment